Publicaciones en las que colabora con FRANCISCO JAVIER BUSTAMANTE SCHNEIDER (18)

2023

  1. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108

2021

  1. Early tacrolimus exposure does not impact long-term outcomes after liver transplantation

    World Journal of Hepatology, Vol. 13, Núm. 3, pp. 362-374

2020

  1. Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again

    American Journal of Transplantation

  2. Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1489-1492

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort

    Liver Transplantation, Vol. 22, Núm. 10, pp. 1391-1400

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  3. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

  4. Safety and Efficacy of Early Everolimus When Calcineurin Inhibitors Are Not Recommended in Orthotopic Liver Transplantation

    Transplantation Proceedings, Vol. 48, Núm. 7, pp. 2506-2509

2012

  1. Biliary complications in orthotopic liver transplantation using choledochocholedochostomy with a T-tube

    Transplantation Proceedings

  2. Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation?

    Transplantation Proceedings

  3. Is antithrombotic prophylaxis required after liver transplantation in HIV-infected recipients?

    American Journal of Transplantation

2011

  1. Advagraf de novo in liver transplantation: A single-center experience

    Transplantation Proceedings

2010

  1. Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation

    Transplantation Proceedings, Vol. 42, Núm. 2, pp. 660-662

2009

  1. Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R-) Liver Transplant Recipients: A Single-Center Experience

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2189-2191

  2. Survival and Hepatitis C Virus Recurrence After Liver Transplantation in HIV- and Hepatitis C Virus-Coinfected Patients: Experience in a Single Center

    Transplantation Proceedings, Vol. 41, Núm. 3, pp. 1041-1043

2003

  1. Liver transplantation for hepatocellular carcinoma in cirrhotic patients

    Transplantation Proceedings

2000

  1. Infeccion despues del trasplante hepatico ortotopico: Analisis de los 120 primeros casos consecutivos

    Revista Clinica Espanola, Vol. 200, Núm. 5, pp. 245-251